St Pharm Co (XKRX:237690) Inventories, Raw Materials & Components: ₩67,973 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:237690 St Pharm Co Ltd XKRX:237690
95 GF Score
Price ₩92,700.00
GF Value ₩115,775.72
Valuation Modestly Undervalued
View Full Analysis

What is St Pharm Co Inventories, Raw Materials & Components?

St Pharm Co XKRX:237690 +0.87% 95 Inventories, Raw Materials & Components is ₩67,973 Mil as of Jun. 2026. GuruFocus rates XKRX:237690 with a GF Score™ of 95/100 and a GF Value™ of ₩115,775.72 (Modestly Undervalued).

St Pharm Co's inventories, raw materials & components for the quarter that ended in Jun. 2026 was ₩67,973 Mil.

St Pharm Co's quarterly raw materials increased from Dec. 2025 (₩60,785 Mil) to Mar. 2026 (₩61,761 Mil) and increased from Mar. 2026 (₩61,761 Mil) to Jun. 2026 (₩67,973 Mil).

St Pharm Co's annual raw materials declined from Dec. 2023 (₩49,274 Mil) to Dec. 2024 (₩48,757 Mil) but then increased from Dec. 2024 (₩48,757 Mil) to Dec. 2025 (₩60,785 Mil).

St Pharm Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for St Pharm Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

St Pharm Co Inventories, Raw Materials & Components Chart

St Pharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34,698.01 56,725.76 49,274.48 48,756.94 60,785.48

St Pharm Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54,572.79 51,735.10 60,785.48 61,761.36 67,972.67
XKRX:237690
95GF Score
St Pharm Co Ltd XKRX:237690
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

St Pharm Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₩67,973 Mil mean?
St Pharm Co (XKRX:237690) has a Inventories, Raw Materials & Components of ₩67,973 Mil as of Jun. 2026. Raw materials are the components a company uses for its main products. View historical data on St Pharm Co and its competitors.
Is St Pharm Co's Inventories, Raw Materials & Components too high?
St Pharm Co's current Inventories, Raw Materials & Components is ₩67,973 Mil. Overall, St Pharm Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does St Pharm Co's Inventories, Raw Materials & Components compare to ZTS?
St Pharm Co's Inventories, Raw Materials & Components of ₩67,973 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on St Pharm Co and its competitors. St Pharm Co's current Inventories, Raw Materials & Components is ₩67,973 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is St Pharm Co stock overvalued right now?
Based on GuruFocus' analysis, St Pharm Co (XKRX:237690) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩115,775.72, compared to a current price of ₩92,700.00 — trading 19.9% below its estimated fair value. The current Inventories, Raw Materials & Components is ₩67,973 Mil. St Pharm Co's overall GF Score™ is 95/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For St Pharm Co (XKRX:237690), the current Inventories, Raw Materials & Components is ₩67,973 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is St Pharm Co (XKRX:237690) Overvalued in 2026?

Based on GuruFocus' analysis, St Pharm Co stock appears to be undervalued. The current stock price of ₩92,700.00 is trading 19.9% below its estimated GF Value™ of ₩115,775.72. GuruFocus considers St Pharm Co to be Modestly Undervalued.

Key valuation signals for XKRX:237690:

  • Inventories, Raw Materials & Components: ₩67,973 Mil
  • GF Value™: ₩115,775.72 vs. price of ₩92,700.00 (19.9% below fair value)
  • GF Score™: 95/100

No single metric tells the full story. See the XKRX:237690 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

St Pharm Co Business Description

Address Teheran Road 78, Gangnam-gu, 7F MSA Building, Daechi-dong, Seoul, KOR, 891-43
St Pharm Co Ltd offers custom manufacturing services of Active pharmaceutical ingredients and their intermediates for their use in pharmaceutical development and be compliant to cGMP, requirements. The firm's business areas include commercial manufacturing of new drug development, manufacturing of generic active pharmaceutical ingredients, fine chemical's business and development of oligonucleotide therapeutics. The company's products comprise small molecule active pharmaceutical ingredients, Anti-cancer, Anti- coagulant active pharmaceutical ingredients, etc.
95GF Score

Get the complete analysis for XKRX:237690

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩92,700.00
Price
₩115,775.72
GF Value